Abaxis covers more than 90% of the general chemical analyzes commonly used in medical and veterinary diagnostics.

About Abaxis

Abaxis was founded on April 1989. Shortly after, Abaxis acquired exclusive patent rights from the national laboratory of Oak Ridge, to develop and produce a biochemical analyzer that is able to perform multiple blood analysis from only one drop of blood.

Abaxis covers more than 90% of general chemical analysis normally used in medical and veterinarian diagnostics. In 2018 it has been acquired by Zoetis.

Zoetis is the world’s leading animal health company, with a portfolio of medicines, vaccines, diagnostic equipment, and technologies to predict, prevent, detect, and treat animal diseases, including infectious, chemical and coagulation testing in Avian, Canine, Bovine and Equine species.

Menu